7
Views
0
CrossRef citations to date
0
Altmetric
Original Papers

Combined Modality Treatment for Locally Advanced Breast Cancer

, , , , , & show all
Pages 589-592 | Published online: 14 Mar 2016
 

Abstract

Purpose: To assess the value of aggressive loco-regional surgery in desperate situations with locally advanced breast cancer .

Methods: In this study there were considered 31 patients with locally advanced breast cancer who underwent surgery in a 5-year period. 10 of them received 3 cycles of chemotherapy and radiotherapy before surgical intervention; the rest of the 21 patients had systemic or local contra-indications for neo-adjuvant therapy. We describe clinical aspects and technical difficulties. Surgical intervention focused on tumour removal and lymph node dissection. Skin defect was covered with flaps according to the Mortimer-Show technique. Postoperatively, the outcome was influenced in a favourable way by the use of Detralex, a micronised flavonoid; all but 2 patients received chemotherapy and locoregional radiotherapy.

Results: 25 patients survived free of disease; from 6 patients who suffered recurrence, 2 are still living and 4 have died. Conclusions: In some forms of locally advanced breast cancer, aggressive surgery offers improvement in the quality of life and increases survival.

Additional information

Notes on contributors

C. Diaconu

Corneliu Diaconu, M.D. Dancinescu street 6 iasi, Ro-6600 Romania Tel.: +40 232 219483 Fax: +40 232 212175

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.